MarketPeel
Insider Trading Intelligence
PS

Paula Soteropoulos

QURE
DIRECTOR · UNIQURE N.V. · CIK 0001692444
FILING MIX · LIFETIME53%/47%
BUYS
26
SELLS
23
TOTAL VALUE
$3.48M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
54,793
AVG SELL PX
$53.48
TRADE KIND
SHOWING 49 / 49
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 11 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Paula Soteropoulos, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+75.00%-4.82%-0.13%-4.69%-2.01%
14d16+62.50%-5.37%+0.64%-6.59%-3.70%
30d16+75.00%-3.84%+0.62%-4.46%-6.73%
60d16(1 pending)+80.00%-11.84%-4.04%-11.34%-12.55%
90d16(1 pending)+73.33%-10.51%-0.82%-9.69%-12.85%
180d16(3 pending)+84.62%-13.95%+6.33%-20.28%-32.67%
1y16(3 pending)+84.62%-33.21%+17.16%-50.37%-65.09%
2y16(3 pending)+92.31%-17.07%+41.85%-58.92%-93.43%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
QURE · 20,203 shares · as of Jun 13, 2024
06,17512,34918,52424,6982021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 26 buys / 23 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
6,0906,090May 21, 2026May 22, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
SALE10b5-1
10b5-1 plan
599$85.47$51.2K0May 8, 2026May 11, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASE
599$8.44$5.1K599May 8, 2026May 11, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
SALE
5990May 8, 2026May 11, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
SALE10b5-1
10b5-1 plan
599$80.11$48.0K0Mar 31, 2026Apr 1, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASE
599$8.44$5.1K599Mar 31, 2026Apr 1, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
SALE
599599Mar 31, 2026Apr 1, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
SALE10b5-1
10b5-1 plan
27,594$78.05$2.15M0Mar 24, 2026Mar 26, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASE
27,594$8.44$232.9K27,594Mar 24, 2026Mar 26, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
SALE
27,5941,198Mar 24, 2026Mar 26, 2026View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
12,50012,500May 22, 2025May 22, 2025View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
28,50028,500May 13, 2025May 15, 2025View →
QURE
UNIQURE N.V.
SALE
2,220$5.14$11.4K20,203Jun 13, 2024Jun 17, 2024View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
11,00011,000May 23, 2024May 28, 2024View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
16,50016,500May 15, 2024May 17, 2024View →
DNTH
DIANTHUS THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
6,5006,500Sep 11, 2023Sep 13, 2023View →
QURE
UNIQURE N.V.
SALE
2,275$18.99$43.2K22,423Jun 16, 2023Jun 20, 2023View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
17,06017,060Jun 13, 2023Jun 20, 2023View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
8,70024,698Jun 13, 2023Jun 20, 2023View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
15,49015,490May 17, 2023May 19, 2023View →
QURE
UNIQURE N.V.
SALE
384$19.97$7.7K15,998Feb 27, 2023Mar 1, 2023View →
QURE
UNIQURE N.V.
PURCHASE
6,000$5.37$32.2K22,382Jan 18, 2023Jan 20, 2023View →
QURE
UNIQURE N.V.
SALE
6,000$22.59$135.5K16,382Jan 18, 2023Jan 20, 2023View →
QURE
UNIQURE N.V.
SALE
6,0002,000Jan 18, 2023Jan 20, 2023View →
QURE
UNIQURE N.V.
PURCHASE
3,80020,182Dec 14, 2022Dec 15, 2022View →
QURE
UNIQURE N.V.
SALE
3,800$23.43$89.0K16,382Dec 14, 2022Dec 15, 2022View →
QURE
UNIQURE N.V.
SALE
3,8000Dec 14, 2022Dec 15, 2022View →
QURE
UNIQURE N.V.
PURCHASE
3,000$5.37$16.1K19,382Dec 13, 2022Dec 15, 2022View →
QURE
UNIQURE N.V.
SALE
3,0008,000Dec 13, 2022Dec 15, 2022View →
QURE
UNIQURE N.V.
SALE
3,000$23.45$70.3K16,382Dec 13, 2022Dec 15, 2022View →
QURE
UNIQURE N.V.
PURCHASE
6,20022,582Nov 29, 2022Dec 1, 2022View →
QURE
UNIQURE N.V.
SALE
6,2003,800Nov 29, 2022Dec 1, 2022View →
QURE
UNIQURE N.V.
SALE
6,200$25.38$157.4K16,382Nov 29, 2022Dec 1, 2022View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
9,08016,382Jun 15, 2022Jun 17, 2022View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
17,81017,810Jun 15, 2022Jun 17, 2022View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
13,44013,440May 24, 2022May 26, 2022View →
QURE
UNIQURE N.V.
SALE
596$16.87$10.1K7,302Feb 28, 2022Mar 2, 2022View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
2,6452,645Feb 24, 2022Feb 28, 2022View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
1,5347,898Feb 24, 2022Feb 28, 2022View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
5,3695,369Jan 3, 2022Jan 5, 2022View →
QURE
UNIQURE N.V.
SALE
504$37.60$19.0K6,364Mar 2, 2021Mar 4, 2021View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
4,1074,107Feb 25, 2021Mar 1, 2021View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
2,3826,868Feb 25, 2021Mar 1, 2021View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
2,0634,486Feb 27, 2020Mar 2, 2020View →
QURE
UNIQURE N.V.
PURCHASEGRANT
Stock grant
3,6203,620Feb 27, 2020Mar 2, 2020View →
QURE
UNIQURE N.V.
SALE
1,300$60.58$78.8K3,245Feb 5, 2020Feb 5, 2020View →
QURE
UNIQURE N.V.
SALE
822$61.53$50.6K2,423Feb 5, 2020Feb 5, 2020View →
QURE
UNIQURE N.V.
SALE
807$62.19$50.2K4,545Jan 28, 2020Jan 30, 2020View →
QURE
UNIQURE N.V.
SALE
3,000$72.18$216.5K5,352Jan 7, 2020Jan 8, 2020View →
Other insiders · QURE
Loading peer insiders…
About this filer
CIK 0001692444
ROLE
Director
PRIMARY
QURE
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001692444DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback